Literature DB >> 3600820

The effect of denbufylline on the viscosity of rat whole blood and on the deformability (filterability) of rat blood cell suspensions.

J J Jukna, C D Nicholson.   

Abstract

The novel alkylxanthine, denbufylline [1,3-di-n-butyl-7-(2-oxopropyl)-xanthine] has been examined, in vitro, for effects on the viscosity of rat whole blood and on the filterability of rat blood cell suspensions. For comparison, pentoxifylline was also examined for rheological activity. Denbufylline reduced the viscosity of whole blood at all shear rates utilised, up to 128.5 s-1. The effect was, however, more pronounced at a low (0.7 s-1) than at a high (94.5 s-1) shear rate indicating that the compound reduces blood cell aggregation and increases blood cell deformability. Denbufylline also increased the filterability of blood cell suspensions. This is further evidence that the compound increases the deformability of blood cells. Denbufylline elevated the filterability of both pure erythrocyte and mixed erythrocyte/leucocyte suspensions, the effect being greatest with the latter. This suggests that denbufylline may influence the deformability of both red and white blood cells. However, the effect on white blood cells, under the experimental conditions employed, is apparently more marked. Pentoxifylline also reduced the viscosity of rat whole blood and increased the filterability of rat blood cell suspensions. However, denbufylline was 10-100-fold more potent in these tests than pentoxifylline.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3600820     DOI: 10.1007/bf00165561

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  Effects of pentoxifylline on red blood cell deformability and blood viscosity under hyperosmolar conditions.

Authors:  H Leonhardt; H G Grigoleit
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-09       Impact factor: 3.000

2.  Microrheology of erythrocytes, blood viscosity, and the distribution of blood flow in the microcirculation.

Authors:  H Schmid-Schönbein
Journal:  Int Rev Physiol       Date:  1976

3.  Blood viscosity of patients with intermittent claudication--concept of "rheological claudication".

Authors:  J Dormandy; E Hoare; J Postlethwaite
Journal:  Biorheology       Date:  1976-06       Impact factor: 1.875

4.  [Pharmacokinetics of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191) in man].

Authors:  H J Hinze
Journal:  Arzneimittelforschung       Date:  1972-09

Review 5.  Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication.

Authors:  H R Dettelbach; D M Aviado
Journal:  J Clin Pharmacol       Date:  1985 Jan-Feb       Impact factor: 3.126

6.  Impaired red cell deformability in peripheral vascular disease.

Authors:  H L Reid; J A Dormandy; A J Barnes; P J Lock; T L Dormandy
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

7.  Blood viscosity in patients with peripheral vascular diseases in the area of low shear rates.

Authors:  B Störmer; R Horsch; F Kleinschmidt; D Loose; H Brüster; K Kremer
Journal:  J Cardiovasc Surg (Torino)       Date:  1974 Sep-Oct       Impact factor: 1.888

8.  Increase in red cell filterability after incubation with oxpentifylline.

Authors:  J Dormandy; E Ernst; P Flute
Journal:  Curr Med Res Opin       Date:  1981       Impact factor: 2.580

9.  Clinical relevance of blood viscosity and red cell deformability including newer therapeutic aspects.

Authors:  J A Dormandy; C J Yates; G A Berent
Journal:  Angiology       Date:  1981-04       Impact factor: 3.619

10.  Filterability of subpopulations of leukocytes: effect of pentoxifylline.

Authors:  E A Schmalzer; S Chien
Journal:  Blood       Date:  1984-08       Impact factor: 22.113

View more
  4 in total

Review 1.  Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia.

Authors:  C D Nicholson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site.

Authors:  C D Nicholson; S A Jackman; R Wilke
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

3.  The low KM-phosphodiesterase inhibitor denbufylline enhances neuronal excitability in guinea pig hippocampus in vitro.

Authors:  B Sutor; C Alzheimer; A Ameri; G ten Bruggencate
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

4.  A pneumotoxin, O,O,S-trimethyl phosphorothioate, induces hemorheological alteration in rats.

Authors:  M L Bezençon; S K Durham; J Roux; E M Grandjean; T Imamura
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.